Marsden PD, 1986. Mucosal leishmaniasis (“espundia” Escomel, 1991). Trans R Soc Trop Med Hyg 80 :859–876.
Zajtchuk JT, Casler JD, Netto EM, Grogl M, Neafie RC, Hessel CR, De Magalhaes AV, Marsden PD, 1999. Mucosal leishmaniasis in Brazil. Laryngoscope 99 :925–939.
Pessoa SB, Barreto MP, 1948. Leishmaniose Tegumentar Americana. Rio de Janeiro: Serviço de Documentação do Ministério da Educação e Saúde. Imprensa Nacional.
Klotz O, Lindenberg H, 1922. The pathology of leishmaniosis of the nose. Am J Trop Med 3 :117–141.
Villela F, Pestana BR, Pessoa SB, 1936. Presença de Leishmania braziliensis na mucosa nasal sem lesão aparente em casos recentes de leishmaniose cutânea. Hospital (Rio J) 16 :953–960.
Reed SG, Badaró R, Masur H, Carvalho EM, Lorenço R, Lisboa A, Teixeira R, Johnson WD, Jones TC, 1986. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 35 :79–85.
Cuba Cuba CA, Marsden PD, Barreto AC, Rocha R, Sampaio RP, Patzlaff L, 1980. Parasitologic and immunologic diagnosis of American cutaneous leishmaniasis. Bol Oficina Sanit Panam 89 :195–208.
Barral A, Pedral-Sampaio D, Grimaldi Junior G, Momem H, Mcmahon-Pratt D, Jesus AR, Almeida R, Badaró R, Barral-Netto M, Carvalho EM, Johnson WD, 1991. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44 :536–546.
Faber WR, Oskam L, Van Gool Kroon NC, Knegt-Junk KJ, Hofwegen H, Van Der Wal AC, Kager PA, 2003. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 49 :70–74.
Oliveira JG, Novais FO, de Oliveira CI, da Cruz Junior AC, Campos LF, da Rocha AV, Boaventura V, Noronha A, Costa JM, Barral A, 2005. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop 94 :55–59.
De Oliveira MR, Macedo VO, De Carvalho EM, Barral A, Marotti JG, Bittencourt A, De Abreu MVA, Orge MGO, Lessa HA, Marsden PD, 1995. Estudo evolutivo da leishmaniose mucosa (7 a 17 anos de seguimento) causada por Leishmania (Viannia) braziliensis em Três Braços, Bahia. Rev Soc Bras Med Trop 28 :325–332.
Osorio LE, Castillo CM, Ochoa MT, 1998. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: Clinical characteristics. Am J Trop Med Hyg 59 :4–52.
Jones TC, Johnson WD Jr, Barretto AC, Lago E, Badaro R, Cerf B, Reed SG, Netto EM, Tada MS, Franca TF, Wiese K, Golightly L, Fikrig J, Costa JML, Cuba CC, Marsden PD, 1987. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 56 :73–83.
Marsden PD, Llanos-Cuentas EA, Lago EL, Cuba CC, Barreto AC, Costa JM, Jones TC, 1984. Human mucocutaneous leishmaniasis in Três Braços, Bahia-Brazil. An area of Leishmania braziliensis braziliensis transmission. III Mucosal disease. Presentation and inicial evolution. Rev Soc Bras Med Trop 17 :179–186.
Schriefer A, Schriefer AL, Goes-Neto A, Guimaraes LH, Carvalho LP, Almeida RP, Machado PR, Lessa HA, de Jesus AR, Riley LW, Carvalho EM, 2004. Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis. Infect Immun 72 :508–514.
de Oliveira CI, Bafica A, Oliveira F, Favali CB, Correa T, Freitas LA, Nascimento E, Costa JM, Barral A, 2003. Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin Infect Dis 37 :149–153.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 581 | 517 | 164 |
Full Text Views | 291 | 10 | 6 |
PDF Downloads | 66 | 8 | 4 |
Mucosal leishmaniasis (ML) is often clinically silent until reaching a highly advanced state. In this prospective study, 6 of 220 patients with early cutaneous leishmaniasis were diagnosed with mucosal involvement by otorhinolaryngological examination (a rate similar to the reported rate of late ML). Detection of early ML may represent an important strategy in preventing severe mucosal destruction in human leishmaniasis.
Marsden PD, 1986. Mucosal leishmaniasis (“espundia” Escomel, 1991). Trans R Soc Trop Med Hyg 80 :859–876.
Zajtchuk JT, Casler JD, Netto EM, Grogl M, Neafie RC, Hessel CR, De Magalhaes AV, Marsden PD, 1999. Mucosal leishmaniasis in Brazil. Laryngoscope 99 :925–939.
Pessoa SB, Barreto MP, 1948. Leishmaniose Tegumentar Americana. Rio de Janeiro: Serviço de Documentação do Ministério da Educação e Saúde. Imprensa Nacional.
Klotz O, Lindenberg H, 1922. The pathology of leishmaniosis of the nose. Am J Trop Med 3 :117–141.
Villela F, Pestana BR, Pessoa SB, 1936. Presença de Leishmania braziliensis na mucosa nasal sem lesão aparente em casos recentes de leishmaniose cutânea. Hospital (Rio J) 16 :953–960.
Reed SG, Badaró R, Masur H, Carvalho EM, Lorenço R, Lisboa A, Teixeira R, Johnson WD, Jones TC, 1986. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 35 :79–85.
Cuba Cuba CA, Marsden PD, Barreto AC, Rocha R, Sampaio RP, Patzlaff L, 1980. Parasitologic and immunologic diagnosis of American cutaneous leishmaniasis. Bol Oficina Sanit Panam 89 :195–208.
Barral A, Pedral-Sampaio D, Grimaldi Junior G, Momem H, Mcmahon-Pratt D, Jesus AR, Almeida R, Badaró R, Barral-Netto M, Carvalho EM, Johnson WD, 1991. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44 :536–546.
Faber WR, Oskam L, Van Gool Kroon NC, Knegt-Junk KJ, Hofwegen H, Van Der Wal AC, Kager PA, 2003. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 49 :70–74.
Oliveira JG, Novais FO, de Oliveira CI, da Cruz Junior AC, Campos LF, da Rocha AV, Boaventura V, Noronha A, Costa JM, Barral A, 2005. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop 94 :55–59.
De Oliveira MR, Macedo VO, De Carvalho EM, Barral A, Marotti JG, Bittencourt A, De Abreu MVA, Orge MGO, Lessa HA, Marsden PD, 1995. Estudo evolutivo da leishmaniose mucosa (7 a 17 anos de seguimento) causada por Leishmania (Viannia) braziliensis em Três Braços, Bahia. Rev Soc Bras Med Trop 28 :325–332.
Osorio LE, Castillo CM, Ochoa MT, 1998. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: Clinical characteristics. Am J Trop Med Hyg 59 :4–52.
Jones TC, Johnson WD Jr, Barretto AC, Lago E, Badaro R, Cerf B, Reed SG, Netto EM, Tada MS, Franca TF, Wiese K, Golightly L, Fikrig J, Costa JML, Cuba CC, Marsden PD, 1987. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 56 :73–83.
Marsden PD, Llanos-Cuentas EA, Lago EL, Cuba CC, Barreto AC, Costa JM, Jones TC, 1984. Human mucocutaneous leishmaniasis in Três Braços, Bahia-Brazil. An area of Leishmania braziliensis braziliensis transmission. III Mucosal disease. Presentation and inicial evolution. Rev Soc Bras Med Trop 17 :179–186.
Schriefer A, Schriefer AL, Goes-Neto A, Guimaraes LH, Carvalho LP, Almeida RP, Machado PR, Lessa HA, de Jesus AR, Riley LW, Carvalho EM, 2004. Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis. Infect Immun 72 :508–514.
de Oliveira CI, Bafica A, Oliveira F, Favali CB, Correa T, Freitas LA, Nascimento E, Costa JM, Barral A, 2003. Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin Infect Dis 37 :149–153.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 581 | 517 | 164 |
Full Text Views | 291 | 10 | 6 |
PDF Downloads | 66 | 8 | 4 |